The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Standard Life Private Equity Trst

8 Sep 2020 12:21

RNS Number : 3693Y
Standard Life Private Eqty Trst PLC
08 September 2020
 

 

London, UK, 8 September 2020

Edison issues review on Standard Life Private Equity Trust (SLPE)

Standard Life Private Equity Trust (SLPET) reported a 5.8% decline in NAV total return (TR) in H120 (based on June NAV estimate), driven mainly by the COVID-19 induced market downturn in March 2020. While macro factors may trigger further declines, the quality of general partners (GPs) chosen by SLPET coupled with good portfolio diversification by region, sector and vintage are key mitigating factors. SLPET's capacity to fund future capital calls is supported by its liquid position (£45.3m at end-July 2020) and the £100m undrawn credit facility, with an overcommitment ratio of 48.1% (close to the mid-point of the targeted 30-75%). SLPET maintains its dividend policy and the shares currently offer an LTM yield of 4.1%.

 

While SLPET's share price dropped sharply in March amid the broader COVID-19 market sell-off, the fact that its NAV is updated with a time lag (based on underlying valuations shared by GPs) resulted in its share price discount widening to a record of close to 60% in March 2020. Subsequently, the discount narrowed to c 24%, close to its 10-year average of c 23% and current peer group average (c 24%).

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Milosz Papst, +44 (0)20 3077 5700

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAUPUBGBUPUGGR
Date   Source Headline
4th Oct 20161:15 pmRNSQuarterly Disclosure
29th Sep 20167:00 amRNSEstimated Net Asset Value as at 31 August 2016
29th Sep 20167:00 amRNSQuarterly Trading Statement
26th Sep 201611:32 amRNSDirector Declaration
14th Sep 20169:45 amRNSUpdate research from QuotedData
1st Sep 20167:00 amRNSTotal Voting Rights
30th Aug 201611:57 amRNSHolding(s) in Company
26th Aug 20162:37 pmRNSTransaction in Own Shares
22nd Aug 20164:19 pmRNSTransaction in Own Shares
17th Aug 201611:42 amRNSTransaction in Own Shares
12th Aug 20167:00 amRNSEstimated Net Asset Value as at 31 July 2016
5th Aug 201610:46 amRNSTransaction in Own Shares
2nd Aug 20168:29 amRNSDirector Declaration
14th Jul 20167:00 amRNSEstimated Net Asset Value at 30 June 2016
4th Jul 20164:43 pmRNSQuarterly Disclosure
14th Jun 20167:00 amRNSEstimated NAV at 31 May 2016
27th May 20164:24 pmRNSCompany Secretary Change
27th May 20167:02 amRNSEstimated NAV at 30 April 2016
27th May 20167:00 amRNSHalf-year Report
10th May 20163:22 pmRNSInitiation research from QuotedData
14th Apr 20167:00 amRNSEstimated NAV at 31 March 2016
5th Apr 201610:00 amRNSHolding(s) in Company
1st Apr 201610:08 amRNSHolding(s) in Company
1st Apr 20169:24 amRNSQuarterly Disclosure
1st Apr 20169:16 amRNSTotal Voting Rights
31st Mar 20162:45 pmRNSTransaction in Own Shares
24th Mar 20162:05 pmRNSEstimated NAV at 29 February 2016
24th Mar 20162:00 pmRNSQuarterly Trading Statement
26th Feb 201610:48 amRNSDirector/PDMR Shareholding
24th Feb 20164:46 pmRNSEdison update on Standard Life Euro. Pvt. Equity
12th Feb 20167:00 amRNSEstimated NAV at 31 January 2016
20th Jan 20163:12 pmRNSResult of AGM
20th Jan 20163:09 pmRNSEstimated NAV at 31 December 2015
6th Jan 201611:49 amRNSQuarterly Disclosure
17th Dec 20155:00 pmRNSAnnual Financial Report
16th Dec 20153:04 pmRNSDirector/PDMR Shareholding
14th Dec 20157:00 amRNSEstimated NAV at 30 November 2015
7th Dec 20157:01 amRNSEstimated NAV at 31 October 2015
7th Dec 20157:00 amRNSPreliminary Results
14th Oct 20157:00 amRNSEstimated NAV at 30 September 2015
1st Oct 20157:30 amRNSQuarterly Disclosure
1st Oct 20157:30 amRNSTotal Voting Rights
25th Sep 20154:36 pmRNSTransaction in Own Shares
18th Sep 201512:02 pmRNSDebt Facility
16th Sep 20157:05 amRNSEstimated NAV at 31 August 2015
16th Sep 20157:00 amRNSQuarterly Trading Statement
14th Aug 20157:00 amRNSEstimated NAV at 31 July 2015
3rd Aug 201510:00 amRNSTotal Voting Rights
31st Jul 201512:42 pmRNSDirector/PDMR Shareholding
30th Jul 20152:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.